Article
Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations.
The Journal of molecular diagnostics : JMD - 1 Apr 2007
Gedge Friederike, McDonald Jamie, Phansalkar Amit, Chou Lan-Szu, Calderon Fernanda, Mao Rong, Lyon Elaine, Bayrak-Toydemir Pinar
Abstract excerpt
Hereditary hemorrhagic telangiectasia is a vascular dysplasia with variable onset and expression. Through identification of a mutation in a proband, mutation testing can be offered to family members. Mutation carriers can receive medical surveillance and treatment before potentially fatal complications arise. In this study, we assessed the significance of clinical evaluations as part of hereditary hemorrhagic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
